A closer look on Rimonabant for Obesity solution

At the latest European Society of Cardiology Congress, new reports about how effective rimonabant is in treating obesity. Rimonabant, an investigational drug produced by Sanofi-Aventis, it’s very effective in helping patients to lose weight and quit smoking. The newest trials with this drug are very promising.

In their latest trial, 1507 overweight and obese persons were treated by receiveing either placebo or one of two doses of rimonabant (5 mg or 20 mg per day.). People taking 20 mg rimonabant had loss weigh very much,but in the same time their lipid profiles improved, compared to people who were on placebo. (Those taking 5 mg still loss more weight than placebo patients, but the weight loss wasn’t that big .) Plus all that, waist measurements improved a lot in persons treated with rimonabant.

In those taking the 20 mg dose, almost 42% of patients lost 11% of their baseline body weight, HDL cholesterol (the good cholesterol) increased by 29%, and triglycerides decreased by 11%. More then that, the number of persons with metabolic syndrome was drop at half at persons taking 20 mg rimonabant.

In conclusion investigators said that rimonabant has a direct positive effect on lipid metabolism.

Is rimonabant really that good can we say that its a real obesity solution?

That we are going to see. While all the positive aspects of rimonabant appear more and more every day,there are few possible side effects,but nothing to worry for now.

Despite the fact that the drug it’s allready on the market its long-term effects (both good and bad) will need to be teased out and after that we can say it is a solution for obesity. Some results from a long-term study with rimonabant, is going to be revealed in November, and this is going to be a major step in the problem of the side effects.One thing its sure Rimonabant acomplia really works and comparing to other weight loss drugs it has few side effects.